{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:36:37Z","timestamp":1792193797482,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1136\/ijgc-00009577-200602001-00002","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T09:54:28Z","timestamp":1551866068000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"special_numbering":"S1","title":["Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals"],"prefix":"10.1016","volume":"16","author":[{"given":"T.","family":"Paulsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kj\u00e6rheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"K\u00e6rn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tretli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Trop\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-00009577-200602001-00002_bib1","series-title":"Cancer in Norway 1998.","year":"2001"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib2","series-title":"Cancer in Norway 2001.","year":"2004"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/ijc.10254","article-title":"Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway","volume":"98","author":"Tingulstad","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0959-8049(95)00501-3","article-title":"Quality of prostate cancer data in the cancer registry of Norway","volume":"32A","author":"Harvei","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1699-0463.1995.tb01121.x","article-title":"Head and neck cancer in Norway. A study of the quality of the Cancer Registry of Norway\u2019s data on head and neck cancer for the period 1953-1991","volume":"103","author":"Mork","year":"1995","journal-title":"APMIS"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib6","first-page":"143","article-title":"Recurrence of ovarian cancer and borderline ovarian tumours in Norway","volume":"11","author":"Paulsen","year":"2001","journal-title":"Nor J Epidemiol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib7","first-page":"499","article-title":"The effect of centralization of primary surgery on survival in ovarian cancer patients","volume":"102","author":"Tingulstad","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib8","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1471-0528.1999.tb08137.x","article-title":"Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients","volume":"106","author":"Junor","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00006250-199903000-00028","article-title":"The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals","volume":"93","author":"Tingulstad","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib11","first-page":"1824","article-title":"The surgical management of women with ovarian cancer in the south west of England","volume":"85","author":"Olaitan","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/gyno.1996.4550","article-title":"Stage IV ovarian cancer: impact of surgical debulking","volume":"64","author":"Curtin","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib13","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/bjc.1994.440","article-title":"The influence of the operating surgeon\u2019s specialisation on patient survival in ovarian carcinoma","volume":"70","author":"Kehoe","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1471-0528.1999.tb08137.x","article-title":"Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients","volume":"106","author":"Junor","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib15","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0090-8258(90)90042-J","article-title":"Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study","volume":"38","author":"Bertelsen","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-8258(92)90100-W","article-title":"The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"47","author":"Hoskins","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/1097-0142(19940715)74:2<656::AID-CNCR2820740218>3.0.CO;2-6","article-title":"Long term survival by cytor-eductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ovarian adenocarcinoma","volume":"74","author":"Baker","year":"1994","journal-title":"Cancer"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/gyno.2000.5926","article-title":"A critique of surgical cytoreduction in advanced ovarian cancer","volume":"78","author":"Covens","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/gyno.1995.1027","article-title":"The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer","volume":"56","author":"Makar","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib21","first-page":"2696","article-title":"Examination, treatment and follow-up of ovarian cancer in Norway","volume":"121","author":"Paulsen","year":"2001","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0021-9681(60)90137-5","article-title":"Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide","volume":"11","author":"Zubrod","year":"1960","journal-title":"J Chronic Dis"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijgo.2004.09.008","article-title":"Symptoms and referral of women with epithelial ovarian tumors","volume":"88","author":"Paulsen","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0090-8258(92)90107-T","article-title":"The impact of subspecialty training on the management of advanced ovarian cancer","volume":"47","author":"Eisenkop","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib25","first-page":"1513","article-title":"Long-term follow-up of patients with advanced ovarian cancer treated in randomised clinical trials","volume":"72","author":"Warwick","year":"1995","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1006\/gyno.2002.6750","article-title":"Does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?","volume":"86","author":"Flynn","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib27","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/ijgc-00009577-200409000-00008","article-title":"Prognostic importance of the time interval from surgery to chemotherapy in treatment of ovarian carcinoma","volume":"14","author":"Sorbe","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/(SICI)1097-0215(19980302)75:5<663::AID-IJC1>3.0.CO;2-X","article-title":"Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993","volume":"75","author":"Bjorge","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib29","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200602001-00002_bib30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ijc.10754","article-title":"Evidence of benefit from centralised treatment of ovarian cancer: a nationwide population-based survival analysis in Finland","volume":"102","author":"Kumpulainen","year":"2002","journal-title":"Int J Cancer"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24191505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24191505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-00009577-200602001-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:10:54Z","timestamp":1753233054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24191505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":30,"aliases":["10.1111\/j.1525-1438.2006.00319.x"],"alternative-id":["S1048891X24191505"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200602001-00002","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200602001-00002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Blackwell Publishing Ltd.","name":"copyright","label":"Copyright"}]}}